HOME >> MEDICINE >> NEWS
EDCTP welcomes G8 support for HIV/AIDS vaccine development

The Hague, the Netherlands On 10th June 2004 during this year's summit in Sea Island, Georgia, the G8 Leaders called for the establishment of a Global HIV Vaccine Enterprise: a virtual consortium to accelerate HIV vaccine development by enhancing coordination, information sharing, and global collaboration. The EDCTP is pleased to see this expression of support and commitment to accelerating the research on and availability of a vaccine against HIV, one of the major impediments today to sustainable development of underprivileged countries.

The European and Developing Countries Clinical Trials Partnership (EDCTP) believes that critical impediments to development such as the ones inflicted by HIV/AIDS, must be addressed by having the Developing Countries benefit from both the tools resulting from research (based on their public health needs), and the systems which they have acquired to assess those tools independently.

The renewed emphasis about HIV expressed by the G8 Leaders is welcome, timely and only too needed. At the same time, we must not forget that the same challenges are being faced with tuberculosis and malaria, as well as other, more neglected causes of illness and poverty in the developing world. The EDCTP strongly believes that ultimately the outcome of this initiative and others will depend on the ownership and commitment to this vision by the partners, and by having the concerned countries play a central role.

Adapted interventions are essential to reduce the burden caused by these diseases. Current approaches to vaccine development suffer from common problems and shortcomings, which are shared by all of these diseases. The EDCTP believes that a common, coordinated approach will benefit and expedite developments in general (i.e. capacities and methodologies).

There are today insufficient capacities and overall capabilities to test products clinically in high-burden countries. The EDCTP upholds high scientific and ethic
'"/>

Contact: Sandor Vrij
vry@edctp.org
31-70-344-0885
Netherlands Organization for Scientific Research
11-Jun-2004


Page: 1 2

Related medicine news :

1. Media invitation first annual EDCTP Forum
2. South African MRC hosts the African branch office of EDCTP Secretariat
3. Americans support most uses of reproductive genetic testing, report on US attitudes reveals
4. Northwestern Memorial Hospital receives $10 million commitment to support preeminent heart program
5. Emergency department study supports giving dehydrated children fluids by mouth
6. Early supported discharge services can reduce long term dependency for stroke patients
7. Care of rural stroke patients improves with telephone support
8. Review supports link between HRT and stroke
9. Chamomile tea: New evidence supports health benefits
10. Psychological support helps adolescents with chronic fatigue syndrome
11. Social supports lessen effects of maltreatment on children vulnerable to depression

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: EDCTP welcomes support for HIV AIDS vaccine development

(Date:7/7/2015)... ... July 07, 2015 , ... The Immune Deficiency Foundation (IDF) ... community using its IDF ePHR, an electronic personal health record powered by Get ... easily track their health information, including symptoms, diagnoses, medications, infusions and other critical ...
(Date:7/7/2015)... ... 07, 2015 , ... Parents and guardians of teenagers or young adults will ... holistic treatment center for drug and alcohol abuse located in Southwest Michigan. A recently ... shown a significant increase in the “club drug” use among high school seniors. The ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... of telemedicine programs in communities throughout Georgia, announces the launch of the first ... rural communities of Hancock County, GA. The new program will not only provide ...
(Date:7/7/2015)... NH (PRWEB) , ... July ... ... integrated, full-service public relations, marketing, and creative design firm, today announced that ... regional public relations and social media campaign, content strategy, and marketing launch ...
(Date:7/7/2015)... Horsham, PA (PRWEB) , ... July 07, 2015 ... ... seasoned financial executive Ellen Purdy as the company’s new Chief Financial Officer, effective ... financial and leadership experience in companies ranging from a multi-billion dollar, global chemical ...
Breaking Medicine News(10 mins):Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 2Health News:Get Real Health Launches New Mobile App for Immune Deficiency Foundation Patient Community 3Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2Health News:Georgia Partnership for TeleHealth prepares to Launch First Ambulance Telemedicine Solution in Georgia 2Health News:TimberNook Selects Calypso Communications for PR, Social Media and Content Strategy 2Health News:Office Practicum Announces new CFO 2
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... technology to treat obesity, metabolic diseases, and other gastrointestinal ... offering of 32,000,000 units. Each unit consists of one share ... purchase one share of common stock at a purchase ... units in the offering would result in them beneficially ...
(Date:7/7/2015)... July 7, 2015 Oasmia ... of drugs within human and veterinary oncology, today ... in the United States , ... leading companion animal therapeutic.      (Logo: ... ) , Paccal Vet-CA1 was ...
Breaking Medicine Technology:Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
Cached News: